Clinical trials: Adhesiveness
Effects of Heat, Tolerability
Evaluation of Experimental Heat Patch
A disposable, air-activated, adhesive backed heat patch is being developed to provide temporary relief from minor muscular ache and joint pains associated with overexertion strains and sprains as well as minor pain associated…
- Conditions
- Effects of Heat, Tolerability, Adhesiveness, Dermal Irritation
- Trial name
- NCT01841788
- Testing
- Thermal Adhesion Patch, Marketed Thermal Adhesion Patch
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Chattem, Inc.
Effects of Heat, Tolerability
Evaluation of Experimental and Commercial Air-Activated, Adhesive Backed Heat Patches
To assess the safety and tolerability for the extended wear of an experimental air-activated self adhesive patch.
- Conditions
- Effects of Heat, Tolerability, Adhesiveness, Dermal Irritation
- Trial name
- NCT01841801
- Testing
- Thermal Adhesive Patch, Marketed Thermal Adhesive Patch
- Where
- United States
- Volunteers
- 157 people, healthy volunteers welcome
- Sponsor
- Chattem, Inc.
Parkinson Disease
An Open, Randomised, Single Dose, 2-period, 2-sequence Crossover Adhesion Study of Two Different Transdermal Patches Containing Rotigotine.
The objective of this study is to evaluate the adhesion of the test product when compared to the reference product following a single transdermal application.
- Trial name
- NCT04183634
- Testing
- Rotigotine TTS (Test), Neupro (Reference)
- Where
- Germany
- Volunteers
- 31 people
- Sponsor
- Sandoz
Adhesiveness
Bar and Ball Joint Overdentures Surface Roughness and Microbial Adherence
The aim of the study was to compare the surface roughness (Ra) of the implant retained mandibular bar overdenture (BOD) and the implant retained mandibular ball joint overdenture (BJOD) in jaw and its relation with the adhesion…
- Trial name
- NCT03256409
- Testing
- Adherence mold and yeast and mesophyll aerobe, Surface Roughness (Ra)
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Gastrovital
Parkinson's Disease
A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease
The primary objective of the study is to compare the adhesiveness of 2 different patch formulations of Rotigotine using the largest patch size of 40 cm^2, under the assumption that both patch formulations show similar…
- Trial name
- NCT02230904
- Testing
- Rotigotine (Test product PR 2.3.1), Rotigotine (Reference product PR 2.1.1)
- Where
- 11 sites in Germany
- Volunteers
- 57 people
- Sponsor
- UCB BIOSCIENCES GmbH
Idiopathic Parkinson Disease
Adhesion and Safety of Rotigexole Compared to Neupro®
A non-inferiority open-labelled crossover randomized controlled trial, of two arms, to investigate the adhesiveness and safety of Rotigexole 8 mg/24 hours transdermal patch, manufactured by Eva pharma, Egypt, compared to the…
- Trial name
- START (NCT07015346)
- Testing
- Rotigexole 8 mg, Neupro ® 8 mg
- Volunteers
- 40 people
- Sponsor
- Eva Pharma
Parkinson Disease
Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease
The investigational medicinal product (IMP) to be tested in the clinical trial (Rotigotine (ROT)-Transdermal System (TDS) (8 mg/24 h)), which is subject to this submission, was designed as a generic of Neupro® 8 mg/24 h, which is…
- Trial name
- NCT06247410
- Testing
- Rotigotine 8Mg/24Hrs Patch
- Where
- 8 sites in Germany
- Volunteers
- 38 people
- Sponsor
- SocraTec R&D GmbH
Parkinson's Disease
Study to Compare Adhesiveness of Two Different Rotigotine Patch Formulations
The primary objective of the study is to compare the adhesiveness of two different patch formulations of rotigotine using patch size 40 cm2, under the assumption that both patch formulations show similar adhesiveness properties.
- Trial name
- NCT01338896
- Testing
- Rotigotine transdermal patch
- Where
- 16 sites in Austria, Germany and 1 more
- Volunteers
- 56 people
- Sponsor
- UCB Pharma
Liver Cirrhosis
Effects of Platelet Mimicking Nanoparticles in Patients With Cirrhosis
Haemostasis of cirrhotic patients is disturbed at different levels: primary haemostasis, coagulation and fibrinolysis, leading to a new haemostatic balance.
- Trial name
- HEMCITAP (NCT06050993)
- Testing
- Additional blood sampling at the same time and in addition of samplings already done for the patient's standard of care.
- Where
- France
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Coronary Artery Disease
Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison
This study will evaluate the 3 drug-eluting stents presently marketed for intervention in the coronary artery with respect to the complications that may occur in case it becomes necessary to retract the stent during the…
- Trial name
- NCT00279006
- Testing
- Percutaneous coronary intervention
- Volunteers
- 150 people
- Sponsor
- Foundation for Cardiovascular Research, Zurich